Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Feb 2023
Historique:
received: 04 01 2023
revised: 12 02 2023
accepted: 13 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

The risk stratification of patients with atrial fibrillation (AF) for subsequent cardiovascular events could help in guiding prevention strategies. In this study, we aimed at investigating circulating microRNAs as prognostic biomarkers for major adverse cardiovascular events (MACE) in AF patients. We conducted a three-stage nested case-control study within the framework of a prospective registry, including 347 AF patients. First, total small RNA-sequencing was performed in 26 patients (13 cases with MACE) and the differential expression of microRNAs was analyzed. Seven candidate microRNAs with promising results in a subgroup analysis on cardiovascular death were selected and measured via using RT-qPCR in 97 patients (42 cases with cardiovascular death). To further validate our findings and investigate broader clinical applicability, we analyzed the same microRNAs in a subsequent nested case-control study of 102 patients (37 cases with early MACE) by using Cox regression. In the microRNA discovery cohort (n = 26), we detected 184 well-expressed microRNAs in circulation without overt differential expression between the cases and controls. A subgroup analysis on cardiovascular death revealed 26 microRNAs that were differentially expressed at a significance level < 0.05 (three of which with an FDR-adjusted

Identifiants

pubmed: 36835272
pii: ijms24043861
doi: 10.3390/ijms24043861
pmc: PMC9964230
pii:
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0
MIRN411 microRNA, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Am Heart Assoc. 2021 Oct 19;10(20):e022304
pubmed: 34612058
Circ Res. 2015 Mar 27;116(7):1143-56
pubmed: 25587098
Thromb Haemost. 2019 Oct;119(10):1563-1572
pubmed: 31421643
Circ Res. 2013 Jan 18;112(2):335-46
pubmed: 23233752
Cell Mol Life Sci. 2013 Mar;70(5):795-814
pubmed: 22825660
Nucleic Acids Res. 2019 Jul 2;47(W1):W530-W535
pubmed: 31114926
RNA. 2017 May;23(5):811-821
pubmed: 28202710
Hum Gene Ther Clin Dev. 2019 Dec;30(4):182-191
pubmed: 31617427
Stroke. 2017 Apr;48(4):828-834
pubmed: 28289238
Biochem Biophys Res Commun. 2016 Aug 5;476(4):607-613
pubmed: 27264952
Biomed Pharmacother. 2022 May;149:112896
pubmed: 35358797
Cell Mol Neurobiol. 2015 Apr;35(3):433-447
pubmed: 25410304
Medicine (Baltimore). 2021 Feb 12;100(6):e24618
pubmed: 33578572
Front Genet. 2019 May 16;10:478
pubmed: 31156715
Atherosclerosis. 2017 Jun;261:26-36
pubmed: 28445809
Stroke. 2021 Mar;52(3):945-953
pubmed: 33563011
Mol Ther. 2020 Jan 8;28(1):157-170
pubmed: 31636041
Br J Surg. 2015 Jun;102(7):755-66
pubmed: 25832031
Gene. 2018 Jan 30;641:172-179
pubmed: 29051025
Biol Proced Online. 2014 Mar 14;16(1):5
pubmed: 24629058
Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9171-9179
pubmed: 31773667
J Geriatr Cardiol. 2013 Sep;10(3):258-66
pubmed: 24133514
Ann Surg. 2015 Nov;262(5):841-7; discussion 847-8
pubmed: 26583674
J Mol Cell Cardiol. 2014 Oct;75:25-39
pubmed: 24976017
Cardiovasc Res. 2016 May 1;110(1):6-22
pubmed: 26912672
BMC Cardiovasc Disord. 2016 Dec 9;16(1):254
pubmed: 27938343
Circ Res. 2014 Sep 26;115(8):696-708
pubmed: 25085941
Circulation. 2010 Dec 7;122(23):2378-87
pubmed: 21098446
J Thromb Thrombolysis. 2018 Feb;45(2):264-273
pubmed: 29264695
Cardiovasc Res. 2019 Sep 1;115(11):1629-1645
pubmed: 30715214
Heart Rhythm. 2013 Jul;10(7):1001-9
pubmed: 23499625
J Mol Cell Cardiol. 2016 Aug;97:162-8
pubmed: 27192016
J Biol Chem. 2012 Aug 3;287(32):27055-64
pubmed: 22692216
Circ Res. 2014 Sep 26;115(8):680-2
pubmed: 25258398
Clin Cancer Res. 2014 Jun 15;20(12):3107-17
pubmed: 24833665
J Am Coll Cardiol. 2012 Jul 24;60(4):290-9
pubmed: 22813605
Oncogene. 2019 Mar;38(11):1892-1904
pubmed: 30390072
Circ Res. 2017 Sep 29;121(8):970-980
pubmed: 28724745
Oncol Res. 2019 Feb 21;27(3):349-358
pubmed: 29716674
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9181-6
pubmed: 24927531
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1214-22
pubmed: 25389315
Front Endocrinol (Lausanne). 2018 Mar 20;9:74
pubmed: 29615970
J Am Heart Assoc. 2021 Mar 16;10(6):e018999
pubmed: 33719498
Cardiovasc Res. 2021 Jan 1;117(1):109-122
pubmed: 32061123
Eur Heart J. 2017 Feb 14;38(7):516-523
pubmed: 27357355
Mol Ther Nucleic Acids. 2019 Mar 1;14:329-338
pubmed: 30665182
Trends Cardiovasc Med. 2017 Oct;27(7):494-503
pubmed: 28602539
Am J Respir Crit Care Med. 2013 Feb 1;187(3):294-302
pubmed: 23220912
Int J Mol Med. 2021 Apr;47(4):
pubmed: 33537835
Front Cardiovasc Med. 2019 Aug 08;6:113
pubmed: 31440517

Auteurs

Stephan Nopp (S)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

M Leontien van der Bent (ML)

Department of Surgery and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 Leiden, The Netherlands.

Daniel Kraemmer (D)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Oliver Königsbrügge (O)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Johann Wojta (J)

Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, 1090 Vienna, Austria.

Ingrid Pabinger (I)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Cihan Ay (C)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Anne Yaël Nossent (AY)

Department of Surgery and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 Leiden, The Netherlands.
Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH